The tumor cell death caused by the nanotherapeutic approach is extremely immunogenic, as demonstrated by the cell surface translocation of calreticulin (CRT) and Heat Shock Protein 70 (Hsp70) and the release of adenosine triphosphate (ATP), which has been shown to promote DC maturation. The gene discussed is CALR; the disease is neoplasm.